ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
16.99024
0.00%
Brent Oil
80.685
-0.75%
Bitcoin
67,859.15
0.20%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Harmony Biosciences Holdings Inc (HRMY)

  7. Harmony Biosciences Holdings Inc (HRMY) Noticias

HRMY

Harmony Biosciences (HRMY)

Harmony Biosciences Holdings Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:HRMY
FechaHoraFuenteTítuloSímboloCompañía
31/05/202407:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
29/05/202416:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:HRMYHarmony Biosciences Holdings Inc
28/05/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN GOLDMAN SACHS 45th ANNUAL GLOBAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
30/04/202406:05GlobeNewswire Inc.Harmony Biosciences Reports Strong First Quarter Financial Results and Acceleration of Its Growth Strategy; Advances Pitolisant Franchise to Extend Revenue Potential Beyond 2040; Strenghtens Sleep/Wake Leadership and Diversifies Into Rare EpilepsyNASDAQ:HRMYHarmony Biosciences Holdings Inc
30/04/202406:00PR Newswire (US)Harmony Biosciences Acquires Epygenix Therapeutics, Inc., Adding Late-Stage Epilepsy Franchise to Growing Pipeline of Innovative CNS AssetsNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/04/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
11/04/202407:05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONISTNASDAQ:HRMYHarmony Biosciences Holdings Inc
03/04/202407:05PR Newswire (US)HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
26/03/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
08/03/202415:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202416:16Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
28/02/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCESNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202415:14Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202407:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:HRMYHarmony Biosciences Holdings Inc
22/02/202406:30GlobeNewswire Inc.Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business UpdatesNASDAQ:HRMYHarmony Biosciences Holdings Inc
21/02/202407:05PR Newswire (US)U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSYNASDAQ:HRMYHarmony Biosciences Holdings Inc
20/02/202407:05PR Newswire (US)HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROMENASDAQ:HRMYHarmony Biosciences Holdings Inc
13/02/202418:06Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/02/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024NASDAQ:HRMYHarmony Biosciences Holdings Inc
26/01/202415:58Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:HRMYHarmony Biosciences Holdings Inc
08/01/202407:05PR Newswire (US)HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCENASDAQ:HRMYHarmony Biosciences Holdings Inc
03/01/202407:05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202315:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:HRMYHarmony Biosciences Holdings Inc
07/12/202307:05PR Newswire (US)HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1NASDAQ:HRMYHarmony Biosciences Holdings Inc
05/12/202307:05PR Newswire (US)HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETINGNASDAQ:HRMYHarmony Biosciences Holdings Inc
16/11/202307:05PR Newswire (US)HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCENASDAQ:HRMYHarmony Biosciences Holdings Inc
15/11/202307:05PR Newswire (US)HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500™NASDAQ:HRMYHarmony Biosciences Holdings Inc
08/11/202307:05PR Newswire (US)HARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD OF DIRECTORSNASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202307:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:HRMYHarmony Biosciences Holdings Inc
31/10/202306:30GlobeNewswire Inc.Harmony Biosciences Reports Strong Third Quarter 2023 Financial ResultsNASDAQ:HRMYHarmony Biosciences Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:HRMY

Su Consulta Reciente

TG
NCYD
Tele2 AB
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados